With more than 10 years of experience in preclinical contract research, project management of regulatory/preclinical/clinical projects, drug development, management consulting and business development, Jonathan has served on core teams responsible for generating investment toward IPOs/share issues (>$70M), and pharmaceutical licensing agreements (>$120M).

 

Jonathan has previously held various roles in preclinical contract research organizations and worked as a management consultant for a range of pharmaceutical and biotechnology companies in the Nordics, where the focus was on providing customers with various services related to business development. Before joining Kye Pharmaceuticals, Jonathan was serving Toronto Innovation Acceleration Partners (TIAP), Paladin Pharma and Kye Pharmaceuticals as a business development consultant. Earlier Jonathan worked as a Business Development Director for a public late-stage oncology Biotech company in Sweden in which he gained experience of licensing drugs to e.g. the Japanese and Canadian market.

 

Jonathan has an MSc in Molecular Biology from the University of Skövde (Sweden)/Helmholtz Centre for Infection Research (Germany) as well as an interdisciplinary MSc in Entrepreneurship & Business Development within Life Science from the University of Gothenburg and Chalmers, Sweden.